COMPANY
AbbraTech Inc.
AbbraTech’s EPIVOLVEsm technology is a generalizable platform capable of driving antibody recognition of any exposed region of a target protein, regardless of the underlying sequence. From company website Source · Oct 12, 2026
Funding and NIH signals
- NIH award NIH awarded $301K (SBIR Phase II 5R44GM156476-03, continuation, notice Aug 25, 2026). NIH RePORTER 5R44GM156476-03 (Aug 25, 2026)
Evidence (1 event)
- Aug 25, 2026 · NIH RePORTER 5R44GM156476-03
Organization: ABBRATECH, INC.; City/State: Branford, CT; Project number: 5R44GM156476-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-25; FY total cost (award amount): 301174; Administering IC: National Institute of General Medical Sciences; Project title: DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE Abs; Organization type: Domestic For-Profits
- Aug 25, 2026 · NIH RePORTER 5R44GM156476-03
Timeline
- Grant Government grant — SBIR: $301,174 (annual award, as published), announced Aug 25, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $551,373 (annual award, as published), announced Jul 17, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1 (annual award, as published), announced Dec 6, 2024. Agency: NIH/NIGMS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $301,174 (annual award, as published), announced Aug 25, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Government grant — SBIR: $551,373 (annual award, as published), announced Jul 17, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
- Government grant — SBIR: $1 (annual award, as published), announced Dec 6, 2024. Agency: NIH/NIGMS. Source: government award database. source ↗
NIH awards 10
- NIH award 1R44GM156476-01 FY2024: $205,926 awarded for that fiscal year; activity R44 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLIC source ↗
- NIH award 5R44GM146473-03 FY2024: $1,121,971 awarded for that fiscal year; activity R44 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Method for the validation by Western analysis source ↗
- NIH award 4R44AI177126-02 FY2024: $995,774 awarded for that fiscal year; activity R44 (SBIR); PI LI, XIAOFENG; recipient as written: ABBRATECH, INC., Branford, CT. Structure-guided neutralizing antibodies developed u source ↗
- NIH award 5R44GM148998-02 FY2024: $1,080,240 awarded for that fiscal year; activity R44 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Platform for the High Throughput Generation a source ↗
- NIH award 2R44GM146473-02 FY2023: $1,121,971 awarded for that fiscal year; activity R44 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Method for the validation by Western analysis source ↗
- NIH award 1R43GM149009-01 FY2023: $295,460 awarded for that fiscal year; activity R43 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. T-cell receptor mimic affinity reagent generati source ↗
- NIH award 1R44AI177126-01 FY2023: $296,100 awarded for that fiscal year; activity R44 (SBIR); PI LI, XIAOFENG; recipient as written: ABBRATECH, INC., Branford, CT. Structure-guided neutralizing antibodies developed u source ↗
- NIH award 1R44GM148998-01 FY2023: $1,080,240 awarded for that fiscal year; activity R44 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Platform for the High Throughput Generation a source ↗
- NIH award 1R43AI167147-01A1 FY2022: $253,440 awarded for that fiscal year; activity R43 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Method for the isolation of antibodies with f source ↗
- NIH award 1R43GM146473-01 FY2022: $339,150 awarded for that fiscal year; activity R43 (SBIR); PI WEINER, MICHAEL P; recipient as written: ABBRATECH, INC., Branford, CT. Method for the validation by Western analysis o source ↗